Format

Send to

Choose Destination
BMC Med. 2009 Nov 16;7:71. doi: 10.1186/1741-7015-7-71.

Migraine pathogenesis and state of pharmacological treatment options.

Author information

1
UCSF Headache Group-Department of Neurology, University of California, San Francisco, CA, USA. till.sprenger@ucsf.edu

Abstract

Migraine is a largely inherited disorder of the brain characterized by a complex, but stereotypical, dysfunction of sensory processing. Often the most obvious clinical symptom is head pain, but non-headache symptoms such as photophobia, phonophobia and nausea are clearly part of the typical presentation. This review discusses the current pathophysiological concepts of migraine and migraine aura, such as a possible brainstem dysfunction and cortical spreading depression. Acute and preventive migraine treatment approaches are briefly covered with a focus on shortcomings of the currently available treatment options. A number of different receptors, such as calcitonin gene-related peptide (CGRP), TRPV1 and glutamate receptors, are currently being targeted by potential novel migraine therapeutics. The prospects of this research are exciting and are likely to improve patient care.

PMID:
19917094
PMCID:
PMC2784479
DOI:
10.1186/1741-7015-7-71
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center